The second podcast from Dr. Ramalingam's excellent webinar on Personalizing Treatment for First Line NSCLC is the question and answer session that followed it, which includes many questions about EGFR-based therapy, antiangiogenic agents, and other relevant issues for individualized treatments for patients.

Here is the audio and video versions of the podcast, along with the figures and transcript for it.

[powerpress]

ramalingam-personalizing-first-line-nsclc-therapy-qa-transcript

ramalingam-personalizing-first-line-nsclc-therapy-qa-transcript

ramalingam-personalizing-first-line-nsclc-therapy-qa-figures

Many thanks to Dr. Ramalingam, who donated his time and effort rather than accept the offered honorarium, and to Eli Lilly Oncology for providing the educational grant that supported this webinar and podcast.